Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2011
11/15/2011US8058425 Purine derivatives as kinase inhibitors
11/15/2011US8058289 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
11/15/2011US8058288 Amido compounds and their use as pharmaceuticals
11/15/2011US8058283 7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
11/15/2011US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011US8058277 Substituted indoles
11/15/2011US8058210 Arylphenyl-substituted cyclic keto-enols
11/15/2011US8058075 Molecular fluorescence sensor for highly sensitive and selective detection of mercury
11/15/2011CA2450473C Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/15/2011CA2385736C Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/10/2011WO2011140431A1 Varenicline salts and crystal forms thereof
11/10/2011WO2011140296A1 Triazoles as inhibitors of fatty acid synthase
11/10/2011WO2011139242A2 Process for the preparation of 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole derivatives
11/10/2011WO2011138935A1 Organic photoelectric conversion element
11/10/2011WO2011138657A1 Aryl substituted olefinic compounds as pde10a inhibitors
11/10/2011WO2011138266A1 Indolizine and imidazopyridine derivatives as orexin receptor antagonists
11/10/2011WO2011137951A1 Organic electroluminescence devices
11/10/2011WO2011137587A1 Cytokine inhibitors
11/10/2011WO2011084433A3 Aza-bridged ring-fused indoles and indolines
11/10/2011WO2010135751A3 Fluorescent cellular markers
11/10/2011WO2010093706A3 Chemically programmed vaccination
11/10/2011WO2010078294A8 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
11/10/2011US20110275822 Salt of tetrahydrotriazolopyridine derivative and crystal thereof
11/10/2011US20110275792 Metal coordinated compositions
11/10/2011US20110275665 Glucokinase activators
11/10/2011US20110275663 N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway
11/10/2011US20110275661 Tricyclic nitrogen compounds used as antibacterials
11/10/2011US20110275660 Beta carboline sulphonylurea derivatives as ep4 receptor antagonists
11/10/2011US20110275657 Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
11/10/2011US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011US20110275647 Pyrimidin-4-(3h)-one derivatives
11/10/2011US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011US20110275628 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
11/10/2011US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011US20110275625 Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/10/2011US20110275623 Bi-functional pyrazolopyridine compounds
11/10/2011US20110275621 Hiv integrase inhibitors
11/10/2011US20110275613 Organic compounds
11/10/2011US20110275611 Chemical compounds
11/10/2011US20110275609 Bicyclic pyrazolo-heterocycles
11/10/2011US20110275608 Piperidine-containing compounds and use thereof
11/10/2011US20110274648 Hepatitis C Virus Inhibitors
11/10/2011DE102010019306A1 Organische Elektrolumineszenzvorrichtungen Organic electroluminescent
11/09/2011EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011EP2385032A1 GPR40 Receptor function regulator
11/09/2011EP2384753A1 Hydantoin derivatives as inhibitors of cellular necrosis
11/09/2011EP2384320A2 Pyrrolidine compounds which modulate the cb2 receptor
11/09/2011EP2069353B1 Polycyclic agents for the treatment of respiratory syncytial virus infections
11/09/2011EP1987030B1 3 -deazapurine derivatives as tlr7 modulators
11/09/2011EP1899330B9 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/09/2011EP1786812B1 Pyridine methylene azolidinones and their use as phosphoinositide inhibitors
11/09/2011CN1934113B Compositions useful as inhibitors of protein kinases
11/09/2011CN102239220A Dye compound, process for producing same, and coloring agent
11/09/2011CN102239168A Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
11/09/2011CN102239167A Imidazopyridine derivatives which inhibit the secretion of gastric acid
11/09/2011CN102239151A Thioamide compounds, method of making and method of using thereof
11/09/2011CN102239147A Quinolone compound and pharmaceutical composition
11/09/2011CN102239146A Novel compounds as calcium channel blockers
11/09/2011CN102238871A Spiroheterocyclic n-oxyamides as pesticides
11/09/2011CN102234279A Sophora flavescens acid derivative, its preparation method and us
11/09/2011CN102234278A (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives, and synthesis method and application thereof
11/09/2011CN102234277A Amino-acid-modified 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acids, and synthesis method and application thereof
11/09/2011CN102234276A Preparation method of optical isomer of stepholidine or its derivative and intermediate used in the method
11/09/2011CN102234275A Deuterated imidazo [1, 2-a] pyridine derivative for treating insomnia, its preparation method and applications
11/09/2011CN102234274A Synthetic method of bicyclic pyridone derivative
11/09/2011CN102234231A 1-substituted-2-substituted-4- aryl substituted-butyl-2-alkene 1, 4-diketone compound, its preparation method and application
11/09/2011CN101712648B Synthesis method of azepine anthraquinone
11/09/2011CN101684101B Piperazinone substituted tetracycline derivatives
11/09/2011CN101619042B Method for synthesizing aromatic pyrimidine-4(3H)-ketone compounds
11/09/2011CN101597290B Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof
11/09/2011CN101273040B Oxadiazolyl pyrazolo-pyrimidines as MGLUR2 antagonists
11/08/2011US8053576 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene
11/08/2011US8053450 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/08/2011US8053445 Utilities of olefin derivatives
11/08/2011US8053442 Organic compounds
11/08/2011CA2618393C Bis-aryl amide compounds and methods of use
11/08/2011CA2499639C Imidazopyridines as cyclin dependent kinase inhibitors
11/08/2011CA2460572C Dual action antibiotics
11/08/2011CA2432185C Substituted pyridoindoles as serotonin agonists and antagonists
11/03/2011WO2011137139A1 Aromatic amic acids or amic esters and compositions
11/03/2011WO2011137109A1 Azaindazole amide compounds as ccr1 receptor antagonists
11/03/2011WO2011136484A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011WO2011136384A1 A process of a quaternary ammonium salt using phosphate
11/03/2011WO2011136383A1 A process of a quaternary ammonium salt
11/03/2011WO2011136292A1 Novel amide derivative and use thereof as medicine
11/03/2011WO2011136264A1 [5,6] heterocyclic compound
11/03/2011WO2011136192A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
11/03/2011WO2011135351A1 Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases
11/03/2011WO2011135259A1 Pyrido[3,2-d]pyrimidine derivatives, processes for preparing same and therapeutic uses thereof
11/03/2011WO2011134971A1 7-(1h-pyrazol-4-yl)-1,6-naphthyridine compounds as syk inhibitors
11/03/2011WO2011134283A1 Matrinic acid/ matrine derivatives and preparation methods and uses thereof
11/03/2011WO2011134019A1 Novel biphenyl sartans
11/03/2011WO2011075699A3 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/03/2011US20110269965 Ring Closing and Related Methods and Intermediates
11/03/2011US20110269791 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
11/03/2011US20110269780 Aza-benzimidazolone chymase inhibitors
11/03/2011US20110269758 Naphthyridinones as protein kinase inhibitors
11/03/2011US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011US20110269752 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
11/03/2011US20110269746 Cyclic compound having hetero atom